Within multiple myeloma (MM), there are biologically different diseases that are distinctly characterized. In this video, Gareth Morgan, MD, FRCP, FRCPath, PhD from the UAMS Myeloma Institute, Little Rock, AR, speaking from the Myeloma 2017 meeting in Edinburgh, UK, talks passionately about this hot topic. He highlights the need for risk-stratified treatment in MM.